This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
PEAK1 Antibody
catalog :
09-274
quantity :
200 μl
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Catalog Number :
09-274
Subcategory :
Cell Structure
Product Name :
Anti-PEAK1 Antibody
Product Type :
Antibodies
Clonality :
Polyclonal Antibody
Gene ID :
Q9H792
Host Name :
Rabbit
Antigen :
PEAK1
Conjugate :
Affinity Purified
Product Description :
Anti-PEAK1 Antibody
Cross Reactivity :
Human
Background :
PEAK1 belongs to the protein kinase superfamily. PEAK1 is also called Tyrosine-protein kinase SgK269 and Sugen kinase 269. It contains a divergent and possibly inactive eukaryotic protein kinase domain. It has one human paralog, known as SgK223 or pragmin. These two constitute the NKF3 subfamily of protein kinases, found in vertebrates and echinoderms.
ALT Names :
NKF3 kinase family member;Sugen kinase 269
Immunogen :
Recombinant Protein, aa: 1511-1660. Homology: 100% human and chimp; 96% pig and horse; 90% mouse; 88% rat
Specificity :
Recombinant Protein, aa: 1511-1660. Homology: 100% human and chimp; 96% pig and horse; 90% mouse; 88% rat
Package Size :
200 μl
Uses :
Western Blotting
Storage :
Maintain at 2-8°C in undiluted aliquots for up to 1 year after date of receipt.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments
